BriaCell Therapeutics Corp.
General ticker "BCTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $80.7M (TTM average)
BriaCell Therapeutics Corp. does not follow the US Stock Market performance with the rate: -35.4%.
Estimated limits based on current volatility of 3.0%: low 4.35$, high 4.62$
Factors to consider:
- Total employees count: 18 (+12.5%) as of 2024
- Top business risk factors: Going concern, Insufficient funding, Economic downturns and volatility, Third-party risks, Labor/talent shortage/retention
- Current price 68.6% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-07-31 to 2026-07-31
- 2024-07-31 to 2025-07-31 estimated range: [34.04$, 156.06$]
- 2025-07-31 to 2026-07-31 estimated range: [14.11$, 63.35$]
Financial Metrics affecting the BCTX estimates:
- Negative: with PPE of -0.7 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -14.25 <= 0.07
- Negative: Shareholder equity ratio, % of -40.57 <= 19.49
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: -0.75 < Inventory ratio change, % of 0
Short-term BCTX quotes
Long-term BCTX plot with estimates
Financial data
| YTD | 2022-07-31 | 2023-07-31 | 2024-07-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $19.44MM | $31.26MM | $45.54MM |
| Operating Income | $-19.44MM | $-31.26MM | $-45.54MM |
| Non-Operating Income | $-14.69MM | $3.99MM | $38.81MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $10.20MM | $20.60MM | $37.14MM |
| Income(Loss) | $-34.13MM | $-27.27MM | $-6.74MM |
| Profit(Loss)* | $-34.13MM | $-27.27MM | $-6.41MM |
| Stockholders Equity | $13.25MM | $-5.04MM | $-3.31MM |
| Assets | $54.60MM | $36.28MM | $8.15MM |
| Operating Cash Flow | $-12.48MM | $-23.74MM | $-24.13MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.62MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-0.68MM |
| Financing Cash Flow | $-3.74MM | $3.95MM | $4.42MM |
| Earnings Per Share** | $-33.04 | $-26.19 | $-5.84 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.